Microbix (TSX: MBX, OTCQX: MBXBF) CEO Cameron Groome joins Adelaide Capital to share the company's journey, key business areas and future plans focused on growth and profitability. This is an introduction to @Microbix designed for new investors or investors looking to better understand the company’s core business lines.
*Correction at 9:46 - *debt-to-equity ratio of below point four**
Microbix Biosystems Inc. creates proprietary biological products for human health, with over 100 skilled employees and sales now targeting C$ 2.0 million monthly. It makes and exports a wide range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, enable assay development and validation or help ensure the quality of clinical diagnostic workflows. Its antigens drive the antibody tests of approximately 100 diagnostics makers, while QAPs are sold to clinical lab accreditation organizations, diagnostics companies, and clinical labs. Microbix QAPs are now available in over 30 countries, supported by a network of international distributors. Microbix is ISO 9001 & 13485 accredited, U.S. FDA registered, Australian TGA registered, Health Canada establishment licensed, and provides CE-marked products.
Microbix also applies its biological expertise and infrastructure to develop other proprietary products and technologies, most notably Kinlytic® urokinase, a biologic thrombolytic drug used to treat blood clots, and reagents or media to support molecular diagnostic testing (e.g., its DxTM™ for patient-sample collection).
Microbix Website: [ Ссылка ]
Corporate Presentation: [ Ссылка ]
--
A new market reality needs to be met with new energy, strategies, and ideas.
Adelaide Capital is a full-service investor relations firm specializing in small/mid-cap companies. We offer a personalized, results-driven approach to connecting businesses with a broad network of investors. Our tailored strategies leverage deep capital markets expertise, social media proficiency, and global investor connections to maximize visibility and drive shareholder value. #AdCap
Site: [ Ссылка ]
X: [ Ссылка ]
LinkedIn: [ Ссылка ]
IG: [ Ссылка ]
Facebook: [ Ссылка ]
CEO.CA: [ Ссылка ]
⚠️ [ Ссылка ]
#AdelaideCapital #SmallCapInvesting #CapitalGrowth #InvestorRelations #GrowthOpportunities #FinancialTrends #InvestmentStrategies #MarketMovers #TrendingStocks #AdCap #Microbix #MBX #Diagnostics #QAPs #DiagnosticSolutions #InvestmentNews #MarketInsights #StockMarketUpdate #LifeScience #LifeSciences #Biotech #Biotechnology
